<DOC>
	<DOCNO>NCT02312856</DOCNO>
	<brief_summary>This study design evaluate safety PulseRider patient undergo treatment bifurcation basilar carotid terminus aneurysm .</brief_summary>
	<brief_title>Adjunctive Neurovascular Support Wide-neck Aneurysm Embolization Reconstruction</brief_title>
	<detailed_description>Primary Endpoints : - Safety : Death stroke downstream territory 180-days post-procedure - Technical Success : Device placement success ability retain coil time index procedure - Rate aneurysm occlusion Day zero ( 0 ) 180 day Additional Evaluations 180-days 365-day follow : - Rate aneurysm occlusion 365 day - Device movement migration - Stenosis - Rate incidence new neurological deficit - Complication rate ( neurological non-neurological )</detailed_description>
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Intracranial Aneurysm</mesh_term>
	<criteria>Patient present angiographically confirm , wide neck intracranial aneurysm locate bifurcation basilar artery carotid terminus artery The target aneurysm vessel diameter 2.7 mm 4.5 mm . The patient 18 year old time consent The patient sign IRB/EC approve informed consent form In opinion physician , placement PulseRider technically feasible clinically indicate Subject mental capacity willing able comply protocol requirement followup Unstable neurological deficit ( condition worsen within last 90 day ) Subarachnoid Hemorrhage ( SAH ) within last 60 day Irreversible bleed disorder mRS score â‰¥3 Patient another aneurysm , Investigator 's opinion , require treatment within follow period ( 365 day ) Platelet count &lt; 100 x 103 cells/mm3 Inability tolerate , adverse reaction contraindication take aspirin clopidogrel A history contrast allergy medically control Known allergy nickel Relative contraindication angiography ( e.g. , serum creatinine &gt; 2.5 mg/dL ) Woman childbearing potential provide negative pregnancy test Evidence active infection Other condition heart , blood , brain intracranial vessel carry high risk neurologic event Evidence disease condition expect compromise survival ability complete followup assessment 365day followup period Extracranial stenosis great 50 % parent artery require access lesion Intracranial stenosis great 50 % treated vessel Extreme vessel tortuosity prohibit appropriate control microguide wire and/or PulseRider delivery wire</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>